Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies (Q71072102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

0 references

0 references

Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

R I Clyman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

5 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

601-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Pulmonary hemodynamics after synthetic surfactant replacement in neonatal respiratory distress syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Ductal patency in neonates with respiratory distress syndrome. A randomized surfactant trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Indomethacin for closure of patent ductus arteriosus in prematures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Prophylactic treatment of asymptomatic patent ductus arteriosus in premature infants with respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Early treatment of patent ductus arteriosus in premature infants with severe respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Indomethacin therapy on the first day of life in infants with very low birth weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Indomethacin reduces the risks of severe intraventricular hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Early intravenous indomethacin prolongs respiratory support in very low birth weight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Early administration of indomethacin to preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

The silent ductus: its precursors and its aftermath

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Beta blockade during and after myocardial infarction: an overview of the randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Timing of indomethacin therapy in persistent ductus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Patent Ductus Arteriosus Increases Lung Fluid Filtration in Preterm Lambs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Effect of patent ductus arteriosus on water accumulation and protein permeability in the lungs of mechanically ventilated premature lambs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Respiratory effects of a patent ductus arteriosus in premature newborn lambs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Pulmonary function in preterm infants following treatment with intravenous indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Improved Lung Compliance following Indomethacin Therapy in Premature Infants with Persistent Ductus Arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Patent Ductus Arteriosus, Indomethacin, and Intestinal Distension: Effects on Intestinal Blood Flow and Oxygen Consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Localized intestinal perforations after enteral administration of indomethacin in premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

The effect of indomethacin on cerebral blood flow and oxygen consumption in the rat at normal and increased carbon dioxide tensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Beagle puppy model of intraventricular hemorrhage: randomized indomethacin prevention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

Indomethacin promotes germinal matrix microvessel maturation in the newborn beagle pup.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2980123-5

10.1016/S0022-3476(96)80123-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8627430%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference